Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Cash from Investing Activities: 2018-2025

Historic Cash from Investing Activities for Evolus (EOLS) over the last 7 years, with Sep 2025 value amounting to -$2.2 million.

  • Evolus' Cash from Investing Activities fell 53.05% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year decrease of 100.10%. This contributed to the annual value of -$4.8 million for FY2024, which is 196.44% down from last year.
  • As of Q3 2025, Evolus' Cash from Investing Activities stood at -$2.2 million, which was up 4.81% from -$2.3 million recorded in Q2 2025.
  • Evolus' 5-year Cash from Investing Activities high stood at $4.8 million for Q1 2021, and its period low was -$2.3 million during Q2 2025.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$1.3 million (2024), whereas its average is -$1.2 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 110.36% in 2021, then slumped by 4,380.95% in 2022.
  • Evolus' Cash from Investing Activities (Quarterly) stood at -$390,000 in 2021, then slumped by 256.67% to -$1.4 million in 2022, then spiked by 74.05% to -$361,000 in 2023, then crashed by 277.29% to -$1.4 million in 2024, then crashed by 53.05% to -$2.2 million in 2025.
  • Its Cash from Investing Activities stands at -$2.2 million for Q3 2025, versus -$2.3 million for Q2 2025 and -$1.9 million for Q1 2025.